PFAROS Driving Sustainable Innovation to Minimise PFAS in European Healthcare
- Coordinator
- Universiteit Gent, Belgium
- Runs
- 1 September 2026 to 31 August 2031
- Status
- Running
- EU funding
- €23.4m
- Total cost
- €41.0m
- Partners
- 89 organisations in 16 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101251281
What the project is doing
In the project's own words, from its summary on CORDIS.
PFAROS is our European game-changing initiative to accelerate the transition away from harmful PFAS substances in the pharmaceutical and medical technology sectors. Aligned with EU public health, environmental, and industrial policy objectives, PFAROS is developing safe, scalable, and regulatory-ready alternatives, ensuring that healthcare innovation and sustainability go hand in hand. PFAROS’ mission is to replace PFAS in medical and pharmaceutical applications through a multidisciplinary approach, combining validated alternatives, advanced degradation and disposal technologies, and data science to support informed substitution and policy action.
At the core of PFAROS is a policy-informed, AI-powered data tool that maps PFAS use, identifies viable alternatives, and integrates life-cycle, exposure, and toxicological data—empowering evidence-based policy and regulatory decisions. Coupled with broad stakeholder engagement and social science integration, the project ensures a just and informed transition. PFAROS will ultimately unlock a PFAS-free future for Europe’s healthcare system by:1.
Developing an integrated testing and assessment framework to implement the safe and sustainable by design approach for PFAS replacement;2. Providing validated, industry-ready PFAS alternatives to ensure rapid adoption;3. Enabling data-driven decision-making through a PFAROS AI-powered data tool tailored to support regulatory needs;4. Setting the gold standard for sustainable alternatives and end-of-life solutions in critical applications;5.
Ensuring broad adoption and fostering cross-sector collaboration with industry, regulators, academia, and civil society;6. Positioning the EU as a global leader in sustainable chemical policy and healthcare innovation. PFAROS is more than a scientific initiative—it is a policy enabler, offering concrete tools and solutions to support a safer, greener, and more resilient healthcare system for Europe. The PFAROS project is a public private partnership (IHI).
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universiteit Gent | Gent | Belgium | Coordinator |
| Universitat Wien | Wien | Austria | Participant |
| Edwards Lifesciences Belgium BV | Dilbeek | Belgium | Participant |
| Health Care Without Harm Europe | Bruxelles / Brussel | Belgium | Participant |
| Inopsys | Mechelen | Belgium | Associatedpartner |
| Ion Beam Applications SA | Ottignies Louvain La Neuve | Belgium | Participant |
| Janssen Pharmaceutica NV | Beerse | Belgium | Participant |
| Terumo Europe | Leuven | Belgium | Participant |
| The European Association Medical Devices-Notified Bodies | Sprimont | Belgium | Participant |
| Ucb Biopharma | Bruxelles / Brussel | Belgium | Participant |
| Ucb Pharma SA | Bruxelles / Brussel | Belgium | Associatedpartner |
| Universiteit Antwerpen | Antwerpen | Belgium | Participant |
| Vlaamse Instelling Voor Technologisch Onderzoek N.v. | Mol | Belgium | Participant |
| Ares Trading SA | Coinsins | Switzerland | Associatedpartner |
| Bayer Consumer Care AG | Basel | Switzerland | Associatedpartner |
| Cilag GmbH International | Zug | Switzerland | Associatedpartner |
| Edwards Lifesciences SARL | Nyon | Switzerland | Associatedpartner |
| F. Hoffmann-La Roche AG | Basel | Switzerland | Participant |
| Merck Serono SA | Geneve | Switzerland | Associatedpartner |
| Novartis Pharma AG | Basel | Switzerland | Participant |
| Roche Diagnostics International AG | Rotkreuz | Switzerland | Associatedpartner |
| Abbvie Deutschland GmbH & Co Kg | Wiesbaden | Germany | Associatedpartner |
| Bayer Aktiengesellschaft | Leverkusen | Germany | Participant |
| Biotronik Se & Co. Kg | Berlin | Germany | Participant |
| Boehringer Ingelheim Internationalgmbh | Ingelheim | Germany | Participant |
| Boehringer Ingelheim Pharma GmbH &co Kg | Ingelheim | Germany | Associatedpartner |
| Boehringer Ingelheim Corporate Center GmbH | Ingelheim am Rhein | Germany | Associatedpartner |
| Dvgw Deutscher Verein Des Gas- Undwasserfaches - Technisch-Wissenschaftlicher Verein eV | Bonn | Germany | Participant |
| Edwards Lifesciences GmbH | Garching B. Munchen | Germany | Associatedpartner |
| ElringKlinger Kunststofftechnik GmbH | Bietigheim-Bissingen | Germany | Associatedpartner |
| Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV | Munchen | Germany | Participant |
| Lilly Deutschland GmbH | Bad Homburg | Germany | Associatedpartner |
| Medicalmountains GmbH | Tuttlingen | Germany | Participant |
| Merck Healthcare Kgaa | Darmstadt | Germany | Associatedpartner |
| Merck Kommanditgesellschaft Auf Aktien | Darmstadt | Germany | Participant |
| Merck Life Science Kgaa | Darmstadt | Germany | Associatedpartner |
| Olympus Winter & Ibe GmbH | Hamburg | Germany | Participant |
| Polysecure GmbH | Freiburg Im Breisgau | Germany | Participant |
| Richard Wolf GmbH | Knittlingen | Germany | Associatedpartner |
| Sanofi-Aventis Deutschland GmbH | Frankfurt Am Main | Germany | Participant |
| Universitaetsklinikum Hamburg-Eppendorf | Hamburg | Germany | Participant |
| Kobenhavns Universitet | Kobenhavn | Denmark | Participant |
| Novo Nordisk A/s | Bagsvaerd | Denmark | Participant |
| Syddansk Universitet | Odense M | Denmark | Participant |
| Terumo Denmark, Filial Af Terumo Sweden AB | Herlev | Denmark | Associatedpartner |
| Edwards Lifesciences SL | Valencia | Spain | Associatedpartner |
| Fundacio Institut Catala De Recerca De L'aigua | Girona | Spain | Participant |
| Merck S.L.U. | Madrid | Spain | Associatedpartner |
| Institut De Recherches Internationales Servier | Gif-Sur-Yvette | France | Participant |
| Merck Santé S.A.S. | Lyon | France | Associatedpartner |
| Oril Industrie | Bolbec | France | Associatedpartner |
| Sanofi R&d Vaccins | Lyon | France | Associatedpartner |
| Sanofi Winthrop Industrie | Gentilly | France | Associatedpartner |
| Sanofi-Aventis Recherche & Developpement | Gentilly | France | Associatedpartner |
| Technologie Servier | Orleans | France | Associatedpartner |
| Terumo France SAS | Rueil-Malmaison | France | Associatedpartner |
| Janssen Sciences Ireland UC | Cork | Ireland | Associatedpartner |
| Pfizer Ireland Pharmaceuticals | Cork | Ireland | Associatedpartner |
| Pfizer Healthcare India Private Limited | TamilNadu | India | Associatedpartner |
| Merck Serono SpA | Roma | Italy | Associatedpartner |
And 29 more organisations. Full list on CORDIS.
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI